Lexicon Pharmaceuticals Inc (LXRX)
1.755
-0.08
(-4.10%)
USD |
NASDAQ |
May 07, 14:29
Lexicon Pharmaceuticals Cash from Investing (TTM): -172.26M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -172.26M |
December 31, 2023 | -49.94M |
September 30, 2023 | -77.67M |
June 30, 2023 | -115.54M |
March 31, 2023 | -54.58M |
December 31, 2022 | -71.08M |
September 30, 2022 | -89.16M |
June 30, 2022 | -12.36M |
March 31, 2022 | 15.43M |
December 31, 2021 | 2.11M |
September 30, 2021 | 40.12M |
June 30, 2021 | 256.32M |
March 31, 2021 | 320.25M |
December 31, 2020 | 380.76M |
September 30, 2020 | 227.26M |
June 30, 2020 | -19.83M |
March 31, 2020 | -105.35M |
December 31, 2019 | -155.86M |
September 30, 2019 | 12.29M |
June 30, 2019 | 99.97M |
March 31, 2019 | 154.79M |
December 31, 2018 | 169.58M |
September 30, 2018 | -24.94M |
June 30, 2018 | 5.711M |
March 31, 2018 | 15.13M |
Date | Value |
---|---|
December 31, 2017 | 50.52M |
September 30, 2017 | 242.75M |
June 30, 2017 | 189.60M |
March 31, 2017 | 194.35M |
December 31, 2016 | 18.25M |
September 30, 2016 | -162.34M |
June 30, 2016 | -118.47M |
March 31, 2016 | -179.67M |
December 31, 2015 | -117.02M |
September 30, 2015 | -163.60M |
June 30, 2015 | -220.86M |
March 31, 2015 | -219.98M |
December 31, 2014 | -108.42M |
September 30, 2014 | 102.07M |
June 30, 2014 | 101.80M |
March 31, 2014 | 111.00M |
December 31, 2013 | 99.54M |
September 30, 2013 | 53.04M |
June 30, 2013 | 44.45M |
March 31, 2013 | 60.88M |
December 31, 2012 | -97.81M |
September 30, 2012 | -73.05M |
June 30, 2012 | -53.95M |
March 31, 2012 | -54.30M |
December 31, 2011 | 69.96M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-172.26M
Minimum
Mar 2024
380.76M
Maximum
Dec 2020
21.54M
Average
-16.09M
Median
Cash from Investing (TTM) Benchmarks
Windtree Therapeutics Inc | -0.015M |
AIM ImmunoTech Inc | -0.832M |
Perspective Therapeutics Inc | 24.37M |
Protalix BioTherapeutics Inc | -16.71M |
Armata Pharmaceuticals Inc | -8.134M |